To further narrow down which hit would be the best therapeutic target, we assessed the association of C5, C5aR1, and C4BPA mRNA expression with prognostic outcomes and found that only high C5aR1 mRNA expression was associated with significantly poor disease-free survival in CRC (Figure 2, B–D). This evidence concerns the gene C4BPA and colorectal carcinoma.